Lorena Simon Gracia
https://www.etis.ee/CV/Lorena_Simon Gracia/estTeenistuskäik
Töökohad ja ametid
16.09.2019–...
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia vanemteadur (1,00)
01.01.2016–...
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (1,00)
01.07.2018–15.09.2019
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (1,00)
02.01.2018–30.06.2018
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Post-doctoral Visit (1,00)
01.01.2018–30.06.2018
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (0,25)
01.07.2017–15.09.2017
Department of Chemistry, University College London, UK. Molecular Bionic Labs, Külalisteadur (1,00)
07.01.2017–30.03.2017
CIC biomaGUNE, San Sebastian, Spain. Soft Matter Nanotechnology Lab, Külalisteadur (1,00)
01.09.2015–31.12.2015
Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut, vähibioloogia teadur (1,00)
01.11.2014–23.12.2014
Department of Chemistry and Biochemistry. University of California San Diego, California, USA, Külalisteadur (0,50)
01.11.2014–23.12.2014
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Külalisteadur (0,50)
21.05.2013–31.08.2015
Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut, teadur (1,00)
01.10.2012–20.05.2013
Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut, teadur (1,00)
01.09.2012–30.09.2012
Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut, teadur (1,00)
01.01.2011–01.08.2012
Institute for Research in Biomedicine, University of Barcelona, Teadur (1,00)
01.03.2010–01.07.2010
Department of Chemistry, University of Sheffield, Doctoral Stay abroad (1,00)
Haridustee
2007–30.09.2011
PhD at the University of Barcelona
15.09.2004–15.09.2008
Bachelor Degree in Biochemistry
15.09.2000–20.07.2005
Bachelor Degree in Chemistry
Lisainfo
Conference "Frontiers in Delivery of Therapeutics". August 2018, Tartu, Estonia;
Spring workshop in Tartu: "Targeting nanosystems for imaging and therapy". May 2017, Tartu, Estonia. Organizer of the workshop;
Gordon Research Seminars: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Invited speaker for oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
Gordon Research Conference: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Poster presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
11th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice. May 2016. Valencia, Spain. Oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
NanoBioMed. Nanobiologia y Nanomedicina. November 2015. Barcelona, Spain. Oral presentation. “Tumor penetrating polymersomes for cancer theranostics”;
EMN Cancun Meeting. Energy Materials Nanotechnology. June 2015. Cancun, Mexico. Oral presentation: “Tumor penetrating pH-sensitive polymersomes for intraperitoneal tumor theranostics” ;
The European Summit for Clinical Nanomedicine and Targeted Medicine. “Paving the way to personalized diagnostics and therapy”. CLINAM (European Foundation for Clinical Nanomedicine). June 2014, Basel, Switzerland. Poster presentation: “Tumor penetrating pH-sensitive polymersomes for cancer theranostics”;
Special Symposium of the Finish Peptide Society. December 2013, Helsinki. Plenary lecture: “Peptide-mediated targeted drug delivery systems for cancer therapy” ;
Kvalifikatsioon
Teaduspreemiad ja tunnustused
2017, Lorena Simon Gracia, Post-doctoral fellowship Mobilitas Plus (MOBJD11)
Institution: Estonian Government
2014, Lorena Simon Gracia, Swiss funded SCOPES Programme of the Swiss National Foundation. Fellowship for the assistance of The European Summit for Clinical Nanomedicine and Targeted Medicine (CLINAM). Switzerland, June 2014.
2010, Lorena Simon Gracia, PhD Fellowship for foreign stays (BE-DGR 2010-Grant for research in a foreign country) Institution: Catalan Government (Generalitat de Catalunya)
2007, Lorena Simon Gracia, PhD Fellowship (FI-DGR 2007-Investigator formation) Institution: Catalan Government (Generalitat de Catalunya)
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 4. Loodusteadused ja tehnika; 4.11. Keemia ja keemiatehnika; CERCS KLASSIFIKAATOR: P390 Orgaaniline keemia
Jooksvad projektid
Lõppenud projektid
Publikatsioonid
Klass
Aasta
Publikatsioon
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
3.1.
2017
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2011
15.08.2019
Lorena Simon Gracia
https://www.etis.ee/CV/Lorena_Simon Gracia/engCareer
Institutions and positions
16.09.2019–...
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow of Cancer Biology (1,00)
01.01.2016–...
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (1,00)
01.07.2018–15.09.2019
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (1,00)
02.01.2018–30.06.2018
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Post-doctoral Visit (1,00)
01.01.2018–30.06.2018
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (0,25)
01.07.2017–15.09.2017
Department of Chemistry, University College London, UK. Molecular Bionic Labs, Visiting Researcher (1,00)
07.01.2017–30.03.2017
CIC biomaGUNE, San Sebastian, Spain. Soft Matter Nanotechnology Lab, Visiting Researcher (1,00)
01.09.2015–31.12.2015
University of Tartu, Faculty of Medicine, Institute of Biomedicine, Research Fellow of Cancer Biology (1,00)
01.11.2014–23.12.2014
Department of Chemistry and Biochemistry. University of California San Diego, California, USA, Visiting Researcher (0,50)
01.11.2014–23.12.2014
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Visiting Researcher (0,50)
21.05.2013–31.08.2015
University of Tartu, Faculty of Medicine, Institute of Biomedicine, Research Fellow (1,00)
01.10.2012–20.05.2013
University of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology, Research Fellow (1,00)
01.09.2012–30.09.2012
University of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology, Research Fellow (1,00)
01.01.2011–01.08.2012
Institute for Research in Biomedicine, University of Barcelona, Researcher (1,00)
01.03.2010–01.07.2010
Department of Chemistry, University of Sheffield, Doctoral Stay abroad (1,00)
Education
2007–30.09.2011
PhD at the University of Barcelona
15.09.2004–15.09.2008
Bachelor Degree in Biochemistry
15.09.2000–20.07.2005
Bachelor Degree in Chemistry
Additional information
Conference "Frontiers in Delivery of Therapeutics". August 2018, Tartu, Estonia;
Spring workshop in Tartu: "Targeting nanosystems for imaging and therapy". May 2017, Tartu, Estonia. Organizer of the workshop;
Gordon Research Seminars: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Invited speaker for oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
Gordon Research Conference: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Poster presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
11th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice. May 2016. Valencia, Spain. Oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
NanoBioMed. Nanobiologia y Nanomedicina. November 2015. Barcelona, Spain. Oral presentation. “Tumor penetrating polymersomes for cancer theranostics”;
EMN Cancun Meeting. Energy Materials Nanotechnology. June 2015. Cancun, Mexico. Oral presentation: “Tumor penetrating pH-sensitive polymersomes for intraperitoneal tumor theranostics” ;
The European Summit for Clinical Nanomedicine and Targeted Medicine. “Paving the way to personalized diagnostics and therapy”. CLINAM (European Foundation for Clinical Nanomedicine). June 2014, Basel, Switzerland. Poster presentation: “Tumor penetrating pH-sensitive polymersomes for cancer theranostics”;
Special Symposium of the Finish Peptide Society. December 2013, Helsinki. Plenary lecture: “Peptide-mediated targeted drug delivery systems for cancer therapy” ;
Qualifications
Honours & awards
2017, Lorena Simon Gracia, Post-doctoral fellowship Mobilitas Plus (MOBJD11)
Institution: Estonian Government
2014, Lorena Simon Gracia, Swiss funded SCOPES Programme of the Swiss National Foundation. Fellowship for the assistance of The European Summit for Clinical Nanomedicine and Targeted Medicine (CLINAM). Switzerland, June 2014.
2010, Lorena Simon Gracia, PhD Fellowship for foreign stays (BE-DGR 2010-Grant for research in a foreign country) Institution: Catalan Government (Generalitat de Catalunya)
2007, Lorena Simon Gracia, PhD Fellowship (FI-DGR 2007-Investigator formation) Institution: Catalan Government (Generalitat de Catalunya)
Fields of research
ETIS CLASSIFICATION: 4. Natural Sciences and Engineering; 4.11. Chemistry and Chemical Technology; CERCS CLASSIFICATION: P390 Organic chemistry
Projects in progress
Completed projects
Publications
Category
Year
Publication
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
3.1.
2017
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2011
15.08.2019
- Leitud 7 kirjet
Programm | Liik | Number | Nimi | Projekti algus | Projekti lõpp | Vastutav täitja | Asutus | Finantseerijapoolne rahastamine | |
---|---|---|---|---|---|---|---|---|---|
MUU | MARMP11194R | Ajukasvajaid penetreerivate peptiidide väljatöötamine | 01.01.2012 | 31.12.2016 | Tambet Teesalu | Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut; Tartu Ülikool, Arstiteaduskond, Bio- ja siirdemeditsiini instituut | 1 499 931,00 EUR | ||
MUU | MARMP11197 | Glioomipenetreerivad peptiidid | 01.01.2012 | 31.12.2016 | Tambet Teesalu | Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut; Tartu Ülikool, Arstiteaduskond, Bio- ja siirdemeditsiini instituut | 250 000,00 EUR | ||
PRG | PRG230 | Hematoentsefaalbarjääri penetreerivad kullerpeptiidid | 01.01.2018 | 31.12.2022 | Tambet Teesalu | Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut | 392 750,00 EUR | ||
1.2.3.4. | MMVBS18435R (823879) | Hemoglobiinil põhinevad nanoosakesed vähkkasvajate ravi võimendamiseks | 01.03.2019 | 28.02.2023 | Tambet Teesalu | Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut | 156 400,00 EUR | ||
MUU | MARBS13184R | Hübriidsete fluorestseeruvate proovide väljatöötamine vähidiagnostikaks | 01.11.2013 | 31.10.2016 | Tambet Teesalu | Tartu Ülikool, Arstiteaduskond, Bio- ja siirdemeditsiini instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut; Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut | 54 600,00 EUR | ||
MUU | MARMP12102 | Kudepenetreerivate kullerpeptiidide väljatöötamine | 01.06.2012 | 31.05.2017 | Tambet Teesalu | Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut; Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut; Tartu Ülikool, Arstiteaduskond, Bio- ja siirdemeditsiini instituut | 1 303 951,00 EUR | ||
MOBJD | MOBJD11 | Polümeersed nano-osakesed glioblastoomi ekperimentaalteraapiaks | 16.09.2017 | 15.09.2019 | Lorena Simon Gracia | Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut | 65 835,00 EUR |